What is AZTR (AZTR) stock price today?

AZTR (AZTR) is currently trading at $0.14, up 0.8% today.

What is AZTR P/E ratio?

AZTR's P/E ratio is -0.09. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is AZTR return on equity (ROE)?

AZTR's return on equity (ROE) is -158.71%, indicating how efficiently the company generates profit from shareholders' equity. This is below the typical market average of 12-15%.

What is AZTR's market cap?

AZTR has a market capitalization of $1.49M.

AMEX · Biotechnology

AZTR (AZTR) Stock

$0.14 +0.80% AMEX: AZTR Healthcare

Valuation

Metric	Value
Price	$0.14
Market Cap	$1.49M
P/E Ratio	-0.09
P/B Ratio	0.31
P/S Ratio	0.00
EPS (TTM)	$-2.25
52-Week High	$1.83
52-Week Low	$0.10
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	-158.71%
ROA	-81.79%
ROCE	-275.00%
Gross Margin	0.00%
Operating Margin	0.00%
Net Margin	0.00%
Debt/Equity	0.04
Current Ratio	3.00

Annual Financials (USD)

Metric	2021	2022	2023	2024	2025
Revenue	$0	$0	$1.0M	$8.0M	$0
Operating Profit	$-9.0M	$-9.0M	$-7.0M	$-11.0B	$-11.0M
Net Profit	$-9.0M	$-11.0M	$-11.0M	$-9.0M	$-11.0M
EPS	$-3.33	$-3.98	$-4.20	$-0.36	$-2.25
Op Margin	-8383.1%	-3328.7%	-1086.1%	-146468.5%	—

Balance Sheet (USD)

Metric	2021	2022	2023	2024	2025
Total Assets	$10.0M	$7.0M	$5.0M	$7.0M	$5.0M
Total Liabilities	$36.0M	$43.0M	$2.0M	$2.0M	$1.0M
Cash	$8.0M	$3.0M	$2.0M	$5.0M	$2.0M
Borrowings	$1.0M	$8.0M	$1.0M	$1.0M	$0

Latest News

/C O R R E C T I O N -- Azitra, Inc./ PR Newswire · Jul 15, 2026 Azitra, Inc. Announces Breakthough Repeat Dose and Anti-Wrinkle Ex Vivo Results for ATR-COSF Program, Demonstrating Increased Distribution and Elasticity PR Newswire · Jul 15, 2026 Azitra, Inc. CEO Issues Letter to Shareholders Detailing Strategic Reorientation Initiatives and Outlook for 2026 and Beyond PR Newswire · Jun 17, 2026 Top Premarket Gainers MT Newswires · Jun 17, 2026 Azitra, Inc. to Present at 2026 BIO International Convention PR Newswire · Jun 16, 2026

Cash Flow (USD)

Metric	2021	2022	2023	2024	2025
Operating Cash Flow	$-8.0M	$-8.0M	$-7.0M	$-10.0M	$-11.0M
Investing Cash Flow	$-1.0M	$-1.0M	$-1.0M	$-1.0M	$0
Financing Cash Flow	$0	$0	$0	$0	$0
Net Cash Flow	$-8.0M	$-5.0M	$-2.0M	$3.0M	$-2.0M
Free Cash Flow	$-9.0M	$-9.0M	$-8.0M	$-11.0M	$-11.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	—
EV / EBITDA	0.54
FCF Yield	-501.53%
Quick Ratio	6.94
Interest Coverage	—
Return 1Y	-90.95%
Return 3Y	-99.98%
Return 5Y	—

Ownership

Insiders Held28.42%

Institutions Held6.27%

Institutions Float Held8.76%

Institutional Holder	Shares	Report Date
Geode Capital Management, LLC	469,878	2026-03-31
UBS Group AG	30,205	2026-03-31
Stonex Group Inc.	22,464	2026-03-31
Tower Research Capital LLC (TRC)	15,085	2026-03-31
Citigroup Inc.	1,705	2026-03-31

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
ENVB	$1.34	+3.88%	-0.04	$799996	0.00%
INDP	$1.39	-3.82%	-0.06	$2.43M	0.00%
JSPR	$0.63	+1.48%	-0.21	$10.24M	0.00%
LIPOLipella Pharmaceuticals Inc.	$0.07	+0.00%	-0.05	$300354	0.00%
ONCO	$0.81	-1.89%	-0.02	$270931	0.00%

About AZTR

AZTR is led by CEO Francisco D. Salva, employs 12 people, headquartered in US, publicly traded since 2023.

AZTR stock trades at $0.14 with a market capitalization of $1.49M. The stock is valued at a price-to-earnings (P/E) ratio of -0.09, price-to-book of 0.31, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.10 and $1.83, and currently trades 92.4% below its 52-week high.

On profitability, AZTR generates a return on equity (ROE) of -158.71%, return on capital employed of -275.00%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks All stock screens

Run Stock Screener Investing Guides